Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
2001 1
2003 2
2005 1
2009 5
2010 4
2011 4
2012 4
2013 6
2014 1
2015 5
2016 4
2017 10
2018 10
2019 7
2020 8
2021 16
2022 12
2023 12
2024 14
2025 18
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
METHODS: We enrolled patients with chronic kidney disease who had an estimated glomerular filtration rate (eGFR) of at least 20 but less than 45 ml per minute per 1.73 m(2) of body-surface area, or who had an eGFR of at least 45 but less than 90 ml per minute per 1.73 m …
METHODS: We enrolled patients with chronic kidney disease who had an estimated glomerular filtration rate (eGFR) of at least 20 but less tha …
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Agrawal N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Zhu D, Dayanandan R, Arimoto R, Mayne KJ, Ng SYA, Sammons E, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney DZI, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Massey D, Brueckmann M, Landray MJ, Baigent C, Haynes R; EMPA-KIDNEY Collaborative Group. EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2025 Feb 20;392(8):777-787. doi: 10.1056/NEJMoa2409183. Epub 2024 Oct 25. N Engl J Med. 2025. PMID: 39453837 Free PMC article. Clinical Trial.
All the patients had an estimated glomerular filtration rate (eGFR) of at least 20 but less than 45 ml per minute per 1.73 m(2) of body-surface area or an eGFR of at least 45 but less than 90 ml per minute per 1.73 m(2) with a urinary albumin-to-creatinine ratio (wi …
All the patients had an estimated glomerular filtration rate (eGFR) of at least 20 but less than 45 ml per minute per 1.73 m(2) of bo …
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Intraperitoneal Chemotherapy: A Call to Study Reproductive Safety for Healthcare Workers.
Gupta P, Godfrey EL, Schultz KS, Yu LJ, Bansal VV, Gomez-Mayorga J, Papageorge M, Proussaloglou EM, Su DG, Merl MY, Ward E, Sood D, Magge DR, Senthil M, Kopecky KE, Turaga KK, Sarpel U; Peritoneal Surface Malignancies (PSM) Consortium Group. Gupta P, et al. Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18051-9. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40877725 No abstract available.
Digital AVATAR therapy for distressing voices in psychosis: the phase 2/3 AVATAR2 trial.
Garety PA, Edwards CJ, Jafari H, Emsley R, Huckvale M, Rus-Calafell M, Fornells-Ambrojo M, Gumley A, Haddock G, Bucci S, McLeod HJ, McDonnell J, Clancy M, Fitzsimmons M, Ball H, Montague A, Xanidis N, Hardy A, Craig TKJ, Ward T. Garety PA, et al. Nat Med. 2024 Dec;30(12):3658-3668. doi: 10.1038/s41591-024-03252-8. Epub 2024 Oct 28. Nat Med. 2024. PMID: 39468363 Free PMC article. Clinical Trial.
RETRACTION: Phytosomal-curcumin Antagonizes Cell Growth and Migration, Induced by Thrombin Through AMP-Kinase in Breast Cancer.
[No authors listed] [No authors listed] J Cell Biochem. 2024 Nov;125(11):e30656. doi: 10.1002/jcb.30656. Epub 2024 Oct 7. J Cell Biochem. 2024. PMID: 39376001
M. Hashemzehi, R. Behnam-Rassouli, S. M. Hassanian, M. Moradi-Binabaj, R. Moradi-Marjaneh, F. Rahmani, H. Fiuji, M. Jamili, M. Mirahmadi, N. Boromand, M. Piran, M. Jafari, A. Sahebkar, A. Avan, and M. ...
M. Hashemzehi, R. Behnam-Rassouli, S. M. Hassanian, M. Moradi-Binabaj, R. Moradi-Marjaneh, F. Rahmani, H. Fiuji, M …
133 results